Sol-Gel Technologies SLGL 深 滬
等待開盤 11-26 09:30:00 美东时间
40.385
-1.375
-3.29%
華盛通- 最 高42.00
- 今 開41.70
- 成交量 1.21万股
- 最 低 38.95
- 昨 收 41.76
- 總市值 1.13亿
- 52周最高 52.26
- 市盈率 靜 --
- 換手率 0.43%
- 52周最低 4.018
- 委 比 -11.89%
- 總股本 278.58万
- 歷史最高 210.00
- 量 比 0.86
- 振 幅 7.30%
- 歷史最低 3.34
- 每 手 1
- 風險率 11.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sol-Gel Technologies Q3 EPS $(2.13) Misses $(2.09) Estimate, Sales $400.000K Beat $300.000K Estimate
Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(2.13) per share which missed the analyst consensus estimate of $(2.09) by 1.91 percent. This is a 1538.46 percent decrease over losses of $(0.13) per
11-20 20:34
Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Sol-Gel Technologies announced its Q3 2025 financial results and updates, highlighting progress on its lead drug candidate SGT-610 for Gorlin syndrome with plans to pursue an additional indication for high-frequency basal cell carcinoma (BCC), potentially doubling its commercial potential. The company also secured Health Canada approval for EPSOLAY and signed a new agreement with Viatris for its distribution in Australia and New Zealand. Financia...
11-20 12:30
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
HC Wainwright & Co. Maintains Buy on Sol-Gel Technologies, Raises Price Target to $50
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Sol-Gel Technologies (NASDAQ:SLGL) with a Buy and raises the price target from $6 to $50.
10-27 19:04
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers ModivCare (NASDAQ:MODV) stock rose 116.1% to $1.21 during Friday's reg...
08-23 01:06
Sol-Gel Technologies Q2 EPS $4.17 Beats $(0.07) Estimate, Sales $17.261M Beat $2.900M Estimate
Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly earnings of $4.17 per share which beat the analyst consensus estimate of $(0.07) by 6057.14 percent. This is a 495.71 percent increase over earnings of $0.70 per
08-15 19:16
Sol-Gel Technologies Q1 EPS $(3.20) Vs. (2.30) Prior Year, Sales $1.03M Miss $1.20M Estimate
Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(3.20) per share. This is a 39.13 percent decrease over losses of $(2.30) per share from the same period last year. The company reported quarterly sales of
05-23 19:25
Sol-Gel Technologies Regains Nasdaq Compliance
Sol-Gel Technologies ( ($SLGL) ) has provided an announcement. Sol-Gel Technolo...
05-23 04:28
Sol-Gel Technologies Gains Nasdaq Extension for Compliance
Sol-Gel Technologies (SLGL) has released an update. Sol-Gel Technologies has be...
2024-11-20 22:49
Sol-Gel announces 180-day extension period for Nasdaq compliance
Sol-Gel Technologies (NASDAQ:SLGL) has received an extension of an additional 180 calendar day period, or until May 19, 2025, to regain compliance with The Nasdaq Stock Market’s minimum bid price rule...
2024-11-20 22:26
